Home Tags Broadcom Inc.

Tag: Broadcom Inc.

Why the Top Analysts Have Mixed Views on Synergy Pharmaceuticals Inc....

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) recently had a low trading volume day. The volume for the company on 19-Nov-18 was recorded to be 4.26 million...

Has Wall Street Now Turned Bullish On Broadcom Inc. (AVGO), Union...

Broadcom Inc. (NASDAQ:AVGO) attracted a lower number of shares in volume with 3.55 million contracts traded on 16-Nov-18. However, its trading capacity stayed around...

Analysts Give These Stocks Mix Nod: Broadcom Inc. (AVGO), Sangamo Therapeutics,...

Broadcom Inc. (NASDAQ:AVGO) recorded a trading volume of 3.63 million shares, below its 90-day volume average of 3.75 million shares. The stock kicked off...

Here is How To Play Bottom in Broadcom Inc. (AVGO), Enbridge...

Broadcom Inc. (NASDAQ:AVGO) recent rally took place on significantly less volume which dipped to nearly 2.53 million contracts on 14-Nov-18 versus its daily average...

Analysts Have Differing Views On Boston Scientific Corporation (BSX), Broadcom Inc....

One of the trending stocks on Tuesday was Boston Scientific Corporation (NYSE:BSX). The number of shares transacted for the day under observation was 3.62...

The Biggest 3 Holders Of Broadcom Inc. (AVGO)

Broadcom Inc. (NASDAQ:AVGO) is on recovery track with 13.26% gain from a 1-year low price of $197.46. The company lost -6.43% to attain the...

Analyst Observation On 2 Stocks: Broadcom Inc. (AVGO), Catalyst Pharmaceuticals, Inc....

Broadcom Inc. (NASDAQ:AVGO) was less active in the last trading session as around 3.35 million shares exchanged hands on Wall Street, representing a decrease...

Broadcom Inc. (AVGO) Institutional Ownership Report

Broadcom Inc. (NASDAQ:AVGO) marched up 21.67% compared to a 52-week low price of $197.46. The shares were last seen trading 2.5% higher, taking the...

What Do Wall Street Analysts Think Of Alliance MMA, Inc. (AMMA),...

Alliance MMA, Inc. (NASDAQ:AMMA) recently ticked higher on weak volume. About 2.66 million contracts were traded on 07-Nov-18 compared to daily average volume of...

2 Value Stocks to Dive Into Now: Neos Therapeutics, Inc. (NEOS),...

Neos Therapeutics, Inc. (NASDAQ:NEOS) is simply too cheap to pass with a price-to-sales ratio of 2.17. The competitors from Drugs - Generic hold an...